| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3337 | Mhi-148 | Near-infrared cyanine dye, acting as an optical imaging agent |
|
| DCC3338 | Mhi-i2 | Novel photodynamic antitumor agent |
|
| DCC3339 | mhy1556 | Novel tyrosinase inhibitor, showing concentration-dependent inhibitory effects with no significant cytotoxicity in cell viability assay |
|
| DCC3340 | mhy218 | Novel potent HDAC inhibitor, possessing potent anticancer activities |
|
| DCC3341 | Mhy219 | Novel potent histone deacetylase (HDAC) inhibitor, inducing apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells |
|
| DCC3342 | mhy336 | Novel topoisomerase II inhibitor, markedly inducing apoptotic cell death via the mitochondria-mediated intrinsic pathway in LNCaP cells |
|
| DCC3343 | mhy384 | Novel tyrosinase inhibitor, down-regulating of MITF and tyrosinase through direct tyrosinase inhibition |
|
| DCC3344 | mhy407 | Novel sensitizer of cancer cells, significantly increasing DNA damage as determined by DNA breakage, levels of damage-responsive proteins, and DNA foci |
|
| DCC3345 | Mhy-449 | Novel inducer of G2/M phase arrest in the cell cycle progression, resulting in growth inhibition and induction of apoptosis in a concentration-dependent manner, and inhibition of proliferation in a time-dependent manner |
|
| DCC3346 | mhy498 | Novel inhibitor of nitric oxide-induced melanogenesis, targeting the NO-induced cGMP signaling pathway |
|
| DCC3347 | mhy-794 | Novel tyrosinase inhibitor, directly inhibiting mushroom tyrosinase |
|
| DCC3348 | Mhy884 | Novel tyrosinase inhibitor, suppressing UVB-induced activation of NF-κB signaling pathway through the downregulation of oxidative stress |
|
| DCC3349 | Mi-1061 | Novel Chemically Stable, Potent, and Efficacious MDM2 Inhibitor |
|
| DCC3350 | Mi-1900 | Novel inhibitor of TMPRSS2, also strongly preventing SARS-CoV-2 multiplication and CPE in Calu-3 cells in a dose-dependent manner. causing strong inhibition of SARS-CoV-2 replication |
|
| DCC3351 | Mi-319 | Novel MDM2 antagonist, restoring p53 functions and increases the life span of orally treated follicular lymphoma bearing animals |
|
| DCC3352 | Mi-432 | Novel matriptase-1/matriptase-2 (MT-1/2) inhibitor, also inhibiting TMPRSS2, proteolytic activation and multiplication of influenza A virus in Calu-3 cells |
|
| DCC3353 | mi-888 Tfa Salt | Highly Potent and Efficacious MDM2 Inhibitor |
|
| DCC3354 | Microtubule Inhibitor 185322 | Novel inhibitor of microtubule assembly, inducung mitotic arrest and apoptosis of MM cells |
|
| DCC3355 | Mif Degrader Md13 | Novel Potent MIF Degrader |
|
| DCC3356 | Mifamurtide | Immunomodulator, regulating the activation of monocytes and macrophages, upregulating the secretion of pro-inflammatory cytokines such as TNF-alpha, IL-1, IL-8, nitric oxide and prostaglandins E2 and D2 |
|
| DCC3357 | Mig-7 Inhibitor D-39 | Novel inhibitor of Migration-Inducting Gene 7 (MIG-7) expression, suppressing EOC cell growth and VEGFA expression |
|
| DCC3358 | Miglustat | Product Description: |
|
| DCC3359 | Milacemide Hydrochloride | MAO-B inhibitor and glycine prodrug, being studied for treatment for the symptoms of Alzheimer's disease |
|
| DCC3360 | Miliusol | Natural anti-tumor agent, demonstrating with tumor inhibitory efficacy comparable or even superior to the mainstay chemotherapeutics paclitaxel or fluorouracil |
|
| DCC3361 | Mina53-in-10 | First-in-class inhibitor of MYC-induced nuclear antigen (MINA53) with selectivity over NO66 and other JmjC oxygenases |
|
| DCC3362 | Minigastrin I (human) | Inhibitor of cholecystokinin B receptors (CCK2) |
|
| DCC3363 | Mip-1072 | Novel inhibitor of the prostate-specific membrane antigen (PSMA) |
|
| DCC3364 | Mip-1095 | Novel inhibitor of the prostate-specific membrane antigen (PSMA) |
|
| DCC3365 | Mipe-1686 | Novel long-lasting myostatin inhibitor, significantly increasing muscle mass and hindlimb grip strength in Duchenne muscular dystrophic model mice |
|
| DCC3366 | Mips1455 | Novel photoactivatable allosteric ligand for the M1 muscarinic acetylcholine receptor |
|
